Poolbeg Pharma PLC POLB.L Stock
Poolbeg Pharma PLC Price Chart
Poolbeg Pharma PLC POLB.L Financial and Trading Overview
| Poolbeg Pharma PLC stock price | 9.8 GBP |
| Previous Close | 8.8 GBP |
| Open | 8.67 GBP |
| Bid | 8.6 GBP x N/A |
| Ask | 8.9 GBP x N/A |
| Day's Range | 8.6 - 9 GBP |
| 52 Week Range | 4 - 11.14 GBP |
| Volume | 131.28K GBP |
| Avg. Volume | 772.59K GBP |
| Market Cap | 44M GBP |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 GBP |
POLB.L Valuation Measures
| Enterprise Value | 28.31M GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.06875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 237.83784 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.404 |
Trading Information
Poolbeg Pharma PLC Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 91.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.14 GBP |
| 52 Week Low | 4 GBP |
| 50-Day Moving Average | 7.52 GBP |
| 200-Day Moving Average | 7.6 GBP |
POLB.L Share Statistics
| Avg. Volume (3 month) | 772.59K GBP |
| Avg. Daily Volume (10-Days) | 860.23K GBP |
| Shares Outstanding | 500M |
| Float | 428.93M |
| Short Ratio | N/A |
| % Held by Insiders | 23.20% |
| % Held by Institutions | 8.49% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.55% |
| Return on Equity (ttm) | -22.91% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5238000 GBP |
| Net Income Avi to Common (ttm) | -4686000 GBP |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.19M GBP |
| Total Cash Per Share (mrq) | 0.03 GBP |
| Total Debt (mrq) | 0 GBP |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 17.759 |
| Book Value Per Share (mrq) | 0.037 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4368000 GBP |
| Levered Free Cash Flow (ttm) | -3360000 GBP |
Profile of Poolbeg Pharma PLC
| Country | United Kingdom |
| State | N/A |
| City | London |
| Address | Queen Mary BioEnterprises Innovation Ctr |
| ZIP | E1 2AX |
| Phone | 44 20 7183 1499 |
| Website | https://www.poolbegpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass broad spectrum RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Q&A For Poolbeg Pharma PLC Stock
What is a current POLB.L stock price?
Poolbeg Pharma PLC POLB.L stock price today per share is 9.8 GBP.
How to purchase Poolbeg Pharma PLC stock?
You can buy POLB.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Poolbeg Pharma PLC?
The stock symbol or ticker of Poolbeg Pharma PLC is POLB.L.
Which industry does the Poolbeg Pharma PLC company belong to?
The Poolbeg Pharma PLC industry is Biotechnology.
How many shares does Poolbeg Pharma PLC have in circulation?
The max supply of Poolbeg Pharma PLC shares is 5M.
What is Poolbeg Pharma PLC Price to Earnings Ratio (PE Ratio)?
Poolbeg Pharma PLC PE Ratio is now.
What was Poolbeg Pharma PLC earnings per share over the trailing 12 months (TTM)?
Poolbeg Pharma PLC EPS is -0.01 GBP over the trailing 12 months.
Which sector does the Poolbeg Pharma PLC company belong to?
The Poolbeg Pharma PLC sector is Healthcare.